{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:31:46Z","timestamp":1780990306102,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1696-5","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T07:21:29Z","timestamp":1448349689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease"],"prefix":"10.1186","volume":"8","author":[{"given":"Antonio","family":"Pisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"3","key":"1696_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2012.08.003","volume":"107","author":"A Pisani","year":"2012","unstructured":"Pisani A, Visciano B, Roux GD, Sabbatini M, Porto C, Parenti G, Imbriaco M. Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. Mol Genet Metab. 2012;107(3):267\u201375.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1696_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cge.12386","volume":"86","author":"A Pisani","year":"2014","unstructured":"Pisani A, Visciano B, Imbriaco M, et al. The kidney of Fabry\u2019s disease. Clin Genet. 2014;86(4):301\u20139.","journal-title":"Clin Genet"},{"issue":"996","key":"1696_CR3","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1259\/bjr\/52065763","volume":"83","author":"M Imbriaco","year":"2010","unstructured":"Imbriaco M, Messalli G, Avitabile G, et al. Cardiac magnetic resonance imaging illustrating Anderson\u2013Fabry disease progression. Br J Radiol. 2010;83(996):e249\u201351.","journal-title":"Br J Radiol"},{"issue":"1","key":"1696_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11547-011-0710-9","volume":"117","author":"G Messalli","year":"2012","unstructured":"Messalli G, Imbriaco M, Avitabile G, et al. Role of cardiac RMN in evaluating patients with Anderson\u2013Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy. Radiol Med. 2012;117(1):19\u201328.","journal-title":"Radiol Med"},{"issue":"2","key":"1696_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","volume":"406","author":"S Ishii","year":"2007","unstructured":"Ishii S, Chang HH, Kawasaki K, Yasuda K, Wu HL, Garman SC, Fan JO. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J. 2007;406(2):285\u201395.","journal-title":"Biochem J"},{"issue":"8","key":"1696_CR6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvorakova L, Ledvinova J, et al. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med. 2005;83(8):647\u201354.","journal-title":"J Mol Med"},{"key":"1696_CR7","first-page":"1799","volume":"1795","author":"CM Eng","year":"1994","unstructured":"Eng CM, Niehaus DJ, Enriquez AL, Burget TS, Ludman MD, Desnick RJ. Fabry disease: twenty three mutations including sense and antisense CpG alterations and identification of a deletional hotspot in the alpha galactosidase A gene. Hum Mol Genet. 1994;1795:1799.","journal-title":"Hum Mol Genet"},{"key":"1696_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-0500-7-11","volume":"7","author":"F Iemolo","year":"2014","unstructured":"Iemolo F, Pizzo F, Albeggiani G, et al. De novo mutation in a male patient with Fabry disease: a case report. BMC Res Notes. 2014;7:7\u201311.","journal-title":"BMC Res Notes"},{"issue":"2","key":"1696_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/humu.1380060214","volume":"6","author":"C Kawanishi","year":"1995","unstructured":"Kawanishi C, Osaka H, Inoue K, Onishi H, Yamada Y, Sugiyama N, Suzuki K, Hanihara T, Miyagawa T, Kimura S. New point mutation (R301X) of the alpha-galactosidase A gene causing Fabry disease. Hum Mutat. 1995;6(2):186\u20137.","journal-title":"Hum Mutat"},{"issue":"7","key":"1696_CR10","first-page":"306","volume":"11","author":"EI Brokalaki","year":"2006","unstructured":"Brokalaki EI, Hentschke M, Grabbe S, Jansen T. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5. Eur J Med Res. 2006;11(7):306\u20138.","journal-title":"Eur J Med Res."},{"issue":"4","key":"1696_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/humu.41","volume":"17","author":"DP Germain","year":"2001","unstructured":"Germain DP, Salard D, Fellman F, et al. Identification of a de novo mutation (G373D) in the alpha-galactosidase A gene (GLA) in a patient affected with Fabry disease. Hum Mutat. 2001;17(4):353.","journal-title":"Hum Mutat"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1696-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:17:06Z","timestamp":1498249026000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1696-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]},"article-number":"711"}}